Patient reported that the new shipment of mini spikes that she got also did not have airtight packaging and therefore patient has concerns about sterility of the supplies.Pharmacist sent email to appropriate escalations and management teams to contact patient to discuss manufacturing concerns.Patient does have 18g needles to use in the meantime to infuse her cuvitru.Patient did not miss a dose or experience an adverse event as a result of the defective product.Defective product lot number and expiration date unknown.Patient does have the defective product on hand for possible return to the manufacturer.No further information provided.Reported to (b)(6) by patient/caregiver.
|